Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Clinical trial NCT00386581 · COMPLETED
Trial details
- NCT number
- NCT00386581
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.